Compare RBB & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RBB | TKNO |
|---|---|---|
| Founded | 2008 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 441.7M | 491.3M |
| IPO Year | 2017 | 2021 |
| Metric | RBB | TKNO |
|---|---|---|
| Price | $25.95 | $8.19 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 8 |
| Target Price | ★ $28.90 | $9.83 |
| AVG Volume (30 Days) | 85.2K | ★ 706.5K |
| Earning Date | 10-19-2026 | 11-04-2026 |
| Dividend Yield | ★ 2.46% | N/A |
| EPS Growth | N/A | ★ 43.86 |
| EPS | ★ 1.99 | N/A |
| Revenue | $5,167,000.00 | ★ $40,520,000.00 |
| Revenue This Year | $4.95 | $13.54 |
| Revenue Next Year | $2.10 | $14.51 |
| P/E Ratio | $13.04 | ★ N/A |
| Revenue Growth | N/A | ★ 7.35 |
| 52 Week Low | $18.45 | $1.91 |
| 52 Week High | $28.24 | $9.48 |
| Indicator | RBB | TKNO |
|---|---|---|
| Relative Strength Index (RSI) | 48.69 | 54.34 |
| Support Level | $25.50 | $6.61 |
| Resistance Level | $26.90 | $9.45 |
| Average True Range (ATR) | 0.56 | 0.68 |
| MACD | 0.01 | 0.14 |
| Stochastic Oscillator | 36.65 | 58.70 |
RBB Bancorp operates as a bank holding company. It provides various banking products and services such as checking, savings, money market accounts, and certificates of deposits. Its Specific services include remote deposit, E-banking, mobile banking, commercial and investor real estate loans, business loans and lines of credit, Small Business Administration (SBA) 7A and 504 loans, mortgage loans, trade finance, and a full range of depository accounts. It generates its revenue from interest received on loans and leases and, to a lesser extent, from interest received on investment securities and derives income from noninterest sources, such as fees received in connection with various lending and deposit services, loan servicing, gain on sales of loans, and wealth management services.
Alpha Teknova Inc is a producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics. Its offer two primary product categories: Lab Essentials and Clinical Solutions. It derives key revenue from the United States. The company offers three primary product types: (i) pre-poured media plates for cell growth and cloning; (ii) liquid microbial culture media and supplements for cellular expansion; and (iii) molecular biology reagents for sample manipulation, resuspension, and purification.